Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Roques

Showing results (381-390 of 558) with videos related to

Pageof 56
Sort By:
Nature Structural Biology|December 1, 1994
NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from SosN Goudreau, F Cornille, M Duchesne, et al.
Neuroscience|August 23, 2005
Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptorsM Mas Nieto, S L E Guen, B L Kieffer, et al.
Biochemical and Biophysical Research Communications|June 13, 1979
Disappearance of energy-transfer as a tool for fluorimetric study of the degradation of enkephalins by aminopeptidase activity from mouse brainA Guyon, J Barbet, B P Roques, et al.
Psychopharmacology|August 1, 1997
CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalinsC Smadja, F Ruiz, P Coric, et al.
Journal of Medicinal Chemistry|January 1, 1992
Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor seriesC Garbay-Jaureguiberry, M C Barsi, A Jacquemin-Sablon, et al.
FEBS Letters|January 20, 1997
Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vprH Y Tung, H De Rocquigny, L J Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarctionW Gonzalez, F Beslot, I Laboulandine, et al.
International Journal of Peptide and Protein Research|September 1, 1989
Inhibitors of the enkephalin degrading enzymes. Modulation of activity of hydroxamate containing compounds by modifications of the C-terminal residueJ Xie, J M Soleilhac, N Renwart, et al.
European Journal of Pharmacology|November 7, 1989
Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slicesT J De Vries, A N Schoffelmeer, P Delay-Goyet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Cyclic cholecystokinin analogues with high selectivity for central receptorsB Charpentier, D Pelaprat, C Durieux, et al.
Pageof 56

Showing results (381-390 of 558) with videos related to

Sort By:
Pageof 56
Nature Structural Biology|December 1, 1994
NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from SosN Goudreau, F Cornille, M Duchesne, et al.
Neuroscience|August 23, 2005
Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptorsM Mas Nieto, S L E Guen, B L Kieffer, et al.
Biochemical and Biophysical Research Communications|June 13, 1979
Disappearance of energy-transfer as a tool for fluorimetric study of the degradation of enkephalins by aminopeptidase activity from mouse brainA Guyon, J Barbet, B P Roques, et al.
Psychopharmacology|August 1, 1997
CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalinsC Smadja, F Ruiz, P Coric, et al.
Journal of Medicinal Chemistry|January 1, 1992
Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor seriesC Garbay-Jaureguiberry, M C Barsi, A Jacquemin-Sablon, et al.
FEBS Letters|January 20, 1997
Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vprH Y Tung, H De Rocquigny, L J Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarctionW Gonzalez, F Beslot, I Laboulandine, et al.
International Journal of Peptide and Protein Research|September 1, 1989
Inhibitors of the enkephalin degrading enzymes. Modulation of activity of hydroxamate containing compounds by modifications of the C-terminal residueJ Xie, J M Soleilhac, N Renwart, et al.
European Journal of Pharmacology|November 7, 1989
Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slicesT J De Vries, A N Schoffelmeer, P Delay-Goyet, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Cyclic cholecystokinin analogues with high selectivity for central receptorsB Charpentier, D Pelaprat, C Durieux, et al.
Pageof 56